Antiviral T cells are thought to regulate whether hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections result in viral control, asymptomatic persistence or severe disease, although the reasons for these different outcomes remain unclear. Recent genetic evidence, however, has indicated a correlation between certain natural killer (NK)-cell receptors and progression of both HIV and HCV infection 1-3 , implying that NK cells have a role in these T-cellassociated diseases. Although direct NK-cell-mediated lysis of virusinfected cells may contribute to antiviral defence during some virus infections-especially murine cytomegalovirus (MCMV) infections in mice and perhaps HIV in humans 4,5 -NK cells have also been suspected of having immunoregulatory functions. For instance, NK cells may indirectly regulate T-cell responses by lysing MCMV-infected antigen-presenting cells 6, 7 . In contrast to MCMV, lymphocytic choriomeningitis virus (LCMV) infection in mice seems to be resistant to any direct antiviral effects of NK cells 5, 8 .
Here we examine the roles of NK cells in regulating T-cell-dependent viral persistence and immunopathology in mice infected with LCMV, an established model for HIV and HCV infections in humans. We describe a three-way interaction, whereby activated NK cells cytolytically eliminate activated CD4 T cells that affect CD8 T-cell function and exhaustion. At high virus doses, NK cells prevented fatal pathology while enabling T-cell exhaustion and viral persistence, but at medium doses NK cells paradoxically facilitated lethal T-cell-mediated pathology. Thus, NK cells can act as rheostats, regulating CD4 T-cell-mediated support for the antiviral CD8 T cells that control viral pathogenesis and persistence.
Intravenous (i.v.) inoculation of C57BL/6 mice with a low (5 3 10 4 plaque-forming units (p.f.u.), medium (2 3 10 5 p.f.u.), or high (2 3 10 6 p.f.u.) dose of LCMV, strain clone 13, resulted in different degrees of pathology, as indicated by weight loss (Fig. 1a ) and by histological analysis of lung sections at day 15 post-infection (p.i.) (Fig. 1b) . The high dose caused a precipitous drop in body weight during the first week of infection ( Fig. 1a, right) but, thereafter, clonal exhaustion and deletion of LCMV-specific T cells resulted in a persistent infection 9,10 associated with minimal lung pathology ( Fig. 1b , right) and 100% (77 of 77) survival ( Fig. 1c, top) . Selective depletion of NK cells using 25 mg of anti-NK1.1 monoclonal antibodies (Supplementary Fig. 1 ) 1 day before high-dose infection resulted in 58% (35 of 65) mortality between days 9 and 13 of infection ( Fig. 1c , top) associated with severe pulmonary oedema (data not shown) and reduced viral titres by day 7 p.i. (Fig. 1d, right ). Under these high-dose conditions, therefore, the presence of NK cells promoted persistence and prevented mortality.
In contrast to the beneficial role of NK cells during high-dose infection, NK-cell depletion prevented the severe weight loss (Fig. 1a , middle) and tissue pathology ( Fig. 1b , middle) associated with the medium dose of LCMV. Twenty-three per cent (7 of 31) of controltreated mice succumbed to the medium dose during the second week of infection, and the lungs of surviving mice exhibited bronchusassociated lymphoid tissue, pulmonary oedema and interstitial mononuclear infiltration. Lung pathology was absent in NK-celldepleted mice, which uniformly survived medium-dose challenge (Fig. 1c, bottom) . Moreover, although high levels of replicating virus persisted in surviving control mice at day 15 p.i., NK-cell depletion resulted in complete viral clearance ( Fig. 1d , middle). In this case the presence of NK cells was detrimental for the host, as they promoted immune pathology and death.
Irrespective of the presence of NK cells, inoculation with a low dose of virus was uniformly non-lethal in 18 of 18 (100%) control and 18 of 18 (100%) of NK-cell-depleted mice by .50 days p.i., with minimal weight loss ( Fig. 1a , left) and minimal lung pathology ( Fig. 1b, left) . Virus was completely cleared in both groups of mice by day 15 of lowdose infection (data not shown), but NK-cell depletion resulted in more rapid elimination of LCMV in liver by day 7 p.i. (Fig. 1d, left) .
The weight loss, lung pathology and mortality observed in mediumdose-infected wild-type mice ( Fig. 1a, b ) did not occur after infection of ab T-cell-receptor-deficient (Tcrb 2/2 )mice, and NK-cell depletion of Tcrb 2/2 mice did not alter weight loss or viral burden ( Supplementary  Fig. 2 ). Thus, NK cells regulate viral clearance and immunopathology during LCMV infection through a T-cell-dependent mechanism.
As early as day 6 after medium-dose infection, the proportion and number of interferon-c (IFN-c) 1 LCMV-specific CD8 T cells was increased two-to sixfold in mice depleted of NK cells ( Fig. 2a and Supplementary Fig. 3 ), and antiviral T cells from these mice showed an enhanced ability to co-produce tumour necrosis factor (TNF) ( Supplementary Fig. 3 ). The number of LCMV epitope NP 396-404 tetramer-binding CD8 T cells in the spleen on day 5 p.i. was increased 4-to 20-fold in NK-cell-depleted mice relative to non-depleted control mice after infection with all doses of virus ( Fig. 2b ). The number of virus-specific IFN-c 1 CD4 T cells was also amplified 7-to 20-fold by NK-cell depletion compared to control mice on different days after medium-dose infection ( Fig. 2c ). Moreover, co-production of TNF and interleukin-2 (IL-2) by antiviral CD4 T cells was augmented by NK-cell depletion ( Fig. 2d and Supplementary Fig. 3 ). The increased magnitude of the LCMV-specific T-cell response in the absence of NK cells during medium-dose infection correlated with rapid viral clearance ( Fig. 2e ). Depletion of NK cells using a carefully titrated dose of anti-asialo GM1 antibody, which eliminates NK cells but not CD8 T cells 11 , also enhanced antiviral CD4 and CD8 T-cell responses during medium-dose infection ( Supplementary Fig. 4 ).
The enhanced antiviral T-cell responses suggested that NK-cell depletion may augment proliferation of LCMV-specific T cells. Transfer of carboxyfluorescein diacetate succinimidyl ester (CFSE)labelled Thy1.1 1 T cells revealed a larger population of CFSE low donor CD4 ( Fig. 2f ) and CD8 (data not shown) T cells in multiple host tissues at day 6 p.i. of high-dose infection in the absence of NK cells. There was also greater specific lysis of viral-peptide-coated target cells as detected by a conventional in vivo cytotoxicity assay at day 4 of infection (Supplementary Fig. 5 ). Moreover, LCMV-specific Ly5.1 1 TCR transgenic (P14) CD8 T cells (transfer 10 4 ) were recovered from tissues of NKcell-depleted recipient (Ly5.2 1 ) mice at two-to ninefold greater numbers than control-treated mice 6 days after low-dose infection ( Supplementary Fig. 5 ). Together these results indicate that NK1.1 1 cells repress the size of the antiviral T-cell response during LCMV infection.
The activities of CD4 T cells are important for maintaining CD8 T-cell function during LCMV infection [12] [13] [14] . To assess whether CD4 T cells were involved in the NK-cell suppression of LCMV-specific CD8 T cells, mice were treated with antibodies to concurrently deplete both NK and CD4 T cells. Whereas depletion of NK cells before mediumdose LCMV infection resulted in a .200-fold reduction in splenic viral titres at day 7 p.i. relative to control and CD4-depleted (DCD4) mice ( Fig. 3a ), depletion of both NK and CD4 T cells (DNKDCD4) had no effect on viral titres. The increase in the number of antiviral CD8 T cells producing more than one cytokine caused by NK-cell depletion was also prevented by co-depletion of CD4 T cells (Fig. 3b ). In contrast, codepletion of NK and CD8 T cells did not prevent an increase in IFN-c 1 LCMV epitope GP 61-80 -specific CD4 T cells (control: 3.8 6 0.5% versus DNK: 9.8 6 0.7% versus DNK/DCD8: 10.7 6 1.6%, n 5 3, P , 0.05 versus control) at day 12 of medium-dose infection.
Paradoxically, at the high virus dose, co-depletion of NK and CD4 T cells prevented the severe pulmonary oedema ( Fig. 3c ) and increased mortality ( Fig. 3d ) associated with depletion of NK cells alone. In this experiment, mice were harvested on day 12 p.i., when three surviving NK-cell-depleted mice were moribund and required euthanasia, whereas all double-depleted mice showed relatively normal vigour. The livers of NK/CD4 double-depleted mice contained 25-fold more p.f.u. than livers from mice depleted of NK cells alone (NK: 5.7 6 0.2 p.f.u. versus DNK/DCD4: 7.1 6 0.1 p.f.u., n 5 5, P , 0.0001). Enhancement of LCMV-specific CD8 T cells in the absence of NK cells was also abrogated by concurrent depletion of CD4 T cells ( Supplementary  Fig. 6 ). Together these data indicate that CD4 T cells are needed for NK-cell modulation of antiviral CD8 T-cell responses associated with viral clearance, persistence and immunopathology.
We used a modified in vivo cytotoxicity assay by injecting splenocytes from medium-dose-infected NK-cell-depleted mice (Ly5.1 1 , day 4 p.i.) into medium-dose-infected NK-cell-depleted (DNK) or isotype IgG2a-treated (control) recipient mice (Ly5.2 1 , day 3 p.i.). After 5 h, similar proportions of total donor T (control: 0.16 6 0.03% versus DNK: 0.15 6 0.02%, n 5 21, P 5 0.80) and B cells (control: 1.8 6 0.2% versus DNK: 1.7 6 0.2%, n 5 21, P 5 0.88) were recovered from infected recipients, regardless of NK-cell depletion. Likewise, recovery of activated (CD44 hi CD43(1B11) 1 ) donor CD8 T cells was similar from spleens of control and DNK mice, with minimal loss relative to uninfected control mice ( Fig. 4a ). In contrast, there was a substantial loss of activated donor CD4 T cells in infected relative to uninfected recipients, and this loss was prevented by depletion of NK cells (Fig. 4a ). The magnitude of NK-cell-dependent loss of activated donor CD4 T cells was similar in low-, medium-and highdose-infected recipients (Fig. 4b ). More activated CD4 T cells, both donor and host derived, in infected (control) mice stained positively for the apoptosis indicator annexin V in comparison to naive donor CD4 T cells or to activated donor CD4 T cells in medium-doseinfected DNK recipient mice (Fig. 4c) . In contrast to activated donor CD4 T cells, the recoveries of naive (CD44 low ) phenotype CD4 and CD8 donor T cells were not altered by NK-cell depletion (data not shown). These data indicate that NK cells in wild-type mice selectively and rapidly target activated CD4 T cells for elimination during LCMV infection.
We next examined the involvement of NK-cell cytolytic mediators Fasl, TNF and perforin (Prf1) in this process. The loss of activated wild-type donor CD4 T cells in infected wild-type recipient mice (Fig. 4a, d ) was seen when activated Fas lpr (Fas mutant) mouse donor cells were transferred into wild-type recipient mice or when wild-type donor cells were transferred into Tnf 2/2 recipient mice ( Fig. 4d ). In contrast, there was relatively little loss of activated wild-type donor CD4 T cells in Prf1 2/2 hosts (Fig. 4d ), whose retention of activated donor CD4 cells was not significantly different (P . 0.1) from that in NK-cell-depleted wild-type or Prf1 2/2 hosts. Thus, NK-cell elimination of activated CD4 T cells is mediated through a perforin-dependent pathway that does not require Fas or TNF. 
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Previous work has implicated NKG2D (also known as Klrk1) in targeting of activated T cells by murine NK cells in vitro [15] [16] [17] , but we observed no differences in activated wild-type donor CD4 T-cell survival in wild-type versus Nkg2d 2/2 recipients (Fig. 4d ) or in wild-type mice treated with a blocking monoclonal antibody to NKG2D 18 (data not shown). Of note is that we did not observe the expression of ligands for activating NK-cell receptors including NKG2D, NKp46 (also known as NCR1), DNAM-1 (also known as CD226) and TRAIL (also known as TNFSF10) on these early activated CD4 T cells, and NK-cell-mediated elimination of activated donor CD4 T cells also occurred in antibodydeficient (mMT 2/2 ) mice (data not shown), precluding a role for antibody-dependent mechanisms. Activated CD4 T cells did, however, express much higher levels of adhesion molecules than naive cells, and these molecules have previously been shown to trigger NK-cell cytotoxicity via LFA-1 19, 20 . Somewhat surprising was the observation that the activated CD4 T cells were far more susceptible than activated CD8 T cells to direct killing by the NK cells, even though both expressed high levels of adhesion molecules. We previously had shown that the presence of the negatively signalling receptor CD244 (2B4) on NK cells prevented NK-cell-mediated lysis of activated CD8 T cells 21 . We found here that although expression of the CD244 ligand CD48 was upregulated on T cells after medium-dose LCMV infection, expression levels of CD48 were much higher on activated CD8 than on activated CD4 cells (mean fluorescence intensity (MFI) of CD48: activated CD4, 3,423 6 147; activated CD8, 6,180 6 166; n 5 9, P , 0.0001) ( Supplementary Fig. 7) .
To assess whether NK-cell-mediated lysis of activated CD4 T cells is a general principle of virus infections, we examined the loss of LCMVactivated CD4 T cells after transfer into mice inoculated with an unrelated Arenavirus, Pichinde virus (PV), the Coronavirus mouse hepatitis virus (MHV), or the interferon inducer and NK-cell activator polyinosinic:polycytidylic acid (polyI:C). All three stimuli induced measureable loss of activated donor CD4 T cells that was dependent upon the presence of NK cells (Fig. 4e ). In reciprocal experiments, CD4 T cells activated during infection with PV, MHV, vaccinia virus (VV) or MCMV were lost upon transfer into mice infected with mediumdose LCMV when NK cells were present (Fig. 4f ).
An analysis, by in vivo cytotoxicity assays after transfer into NKcell-sufficient mice, of the window of time during which NK-cell regulation of T cells occurred in the LCMV medium-dose model showed reduced frequencies of activated donor CD4 T cells relative to uninfected recipients 1 (43%), 2 (32%), 3 (26%), 4 (4%) and 5 (8%) days after infection ( Supplementary Fig. 8 ). The frequencies of activated donor CD4 T cells were increased by NK-cell depletion in recipient mice only at day 2 and day 3 p.i. These results indicate that NK cells target activated CD4 T cells mainly on the second and third day of infection, when the cytolytic activity of NK cells is at its peak 22 .
These results show that NK cells can have a crucial role in controlling virus-associated morbidity, mortality and persistence in the absence of direct NK-cell-mediated control of virus replication, and they do so by altering the numbers and polyfunctionality of virusspecific T cells. Their effect on activated CD4 T cells was presumably due to direct cytotoxicity, as demonstrated by rapid perforin-dependent elimination of activated CD4 T cells by NK cells in short-term in vivo cytotoxicity assays and the observation of enhanced annexin reactivity 
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of CD4 T cells in the presence of NK cells. The effect of activated NK cells on CD8 T cells and virus clearance seemed to be indirect, and depended on the presence of CD4 T cells, which are known to produce factors that preserve CD8 T-cell viability and functionality 12, 13, [23] [24] [25] . This suggests a three-way interaction, whereby NK cells suppress the CD4 T-cell response, thereby preventing augmentation of the CD8 T-cell response, which, in turn, directly regulates viral clearance and immunopathology in this system (Fig. 4f ).
Our observation of direct NK-cell-mediated lysis of T cells during virus infection is distinct from published accounts of NK-cell regulation of antiviral T cells during MCMV infection, in which NKcell-mediated lysis of virus-infected cells contributes to control of viral burden and persistence of MCMV-infected dendritic cells that
in turn regulate activity of antiviral T cells 6, 7, 26 . Moreover, we found no NK-cell-dependent changes in the number and antigen-presenting function of splenic dendritic cells during LCMV infection (Supplementary Fig. 9 ), consistent with our finding that NK cells directly regulated the T cells. A possible concern was that in vivo cellular depletion with antibodies against NK1.1 and CD4 have the potential to affect frequencies of NKT, cd T and regulatory T cells, but the frequencies of these lymphocytes in the spleen of LCMV-infected mice were not altered after 3 to 4 days of infection by the low concentration of anti-NK1.1 used in these studies ( Supplementary Figs 1 and 10) .
Moreover, depletion of NK cells in cd T-cell-deficient (Tcrd 2/2 ) and NK T-cell-deficient (Cd1d 2/2 ) mice during medium-dose infection enhanced LCMV-specific T-cell responses and reduced viral loads ( Supplementary Fig. 9 ), similar to that in wild-type mice. Therefore, these lymphocyte lineages seem to be dispensable for NK-cell immunoregulatory function during LCMV infection.
By adjusting the dose of the LCMV inocula, it is possible to generate diverse patterns of CD8 T-cell-regulated pathogenesis, similar to the variety of pathogenic patterns a human HCV infection can take, including rapid viral clearance, severe T-cell-dependent immunopathology and long-term persistence. We show here that at a high dose of LCMV, NK cells act beneficially by suppressing T-cell responses, thereby preventing severe pathology and mortality while enabling the development of a persistent infection from which mice eventually recover and clear the virus 27 . At the medium-dose inoculum, NK-cell suppression of T cells is detrimental to the host, as virus clearance is impaired due to the limited number and functionality of T cells. However, a medium dose of virus is not sufficient for complete clonal exhaustion of T cells, ultimately resulting in severe T-cell-dependent immunopathology that can lead to death of the host.
These results indicate that NK cells can serve as rheostats, or master regulators, of antiviral T-cell responses. Consistent with the fact that many virus infections induce cytokines that potently activate NK cells 28 , we found that NK-cell lysis of activated CD4 T cells was triggered by several viruses as well as after inoculation with polyI:C, which induces interferon and activates NK cells. Although a previous study found that NK-cell depletion did not alter the magnitude of antiviral T-cell responses during infection with the Armstrong strain of LCMV 29 , we have observed enhanced antiviral T-cell responses and improved viral control at early time points after infection of NK-celldepleted mice with both LCMV Armstrong and Pichinde virus (S.N.W., unpublished observations). Thus, the timing and the type of evaluation may be important to detect detrimental effects of NK cells on T cells during more benign viral infections.
METHODS SUMMARY
Infection model. One day before infection, male C57BL/6 mice were selectively depleted of NK cells through a single intraperitoneal (i.p.) injection of 25 mg anti-NK1.1 monoclonal antibody (PK136) or a control mouse IgG2a (both from Bio-X-Cell), as previously described 21 (Supplementary Fig. 1 ). In some cases, mice were also depleted of CD4 T cells by i.p. injection of 100 mg anti-CD4 (GK1.5) at days 21 and 13 of infection. Mice were then infected i.v. with 5 3 10 4 (low dose), 2 3 10 5 (medium dose) or 2 3 10 6 (high dose) p.f.u. of the clone 13 variant of LCMV. Virus was titrated by plaque assay on Vero cells. In some experiments, mice were inoculated i.p. with 1.5 3 10 7 p.f.u. of PV, 8 3 10 5 p.f.u. of MHV strain A59, 1 3 10 6 p.f.u. of VV strain Western Reserve, 1 3 10 6 p.f.u. of Smith strain MCMV, or 200 mg of polyI:C (Invivogen). Immune assays. The number of LCMV-specific T cells was measured by H-2D b -NP 396-404 tetramer staining or by intracellular cytokine staining after 5 h ex vivo stimulation with 1 mM viral peptide in the presence of brefeldin A. T-cell cytolytic activity was measured in vivo as described previously 21 . In vivo NK-cell assay. An unconventional in vivo cytotoxicity assay was previously established to determine NK-cell killing of lymphocyte populations 21 . Donor mice were depleted of NK cells and then infected i.v. or i.p. with different viruses. At day 4 p.i., single-cell splenocyte suspensions were prepared from these mice, labelled with 2 mM CFSE, and transferred (2 3 10 7 ) into various strains of NK-celldepleted or control recipient mice that were either uninfected or had been infected with virus 1-5 days previously. Spleens of recipient mice were harvested 5 h after transfer and assessed for survival of donor T cells. LETTER RESEARCH
